drugset / Trial / NCT00655486
Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to allow eligible subjects from the parent study, SP925 \[NCT00655551\] to continue lacosamide and to obtain additional long-term safety data
Timeline
- Start
- 2008-04
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lacosamide | Other / unclassified | 100 mg | Intravenous |
| Subject | Lacosamide | Other / unclassified | 800 mg | Intravenous |